R. Brent Mattis joined the Cleveland Clinic in 2017 where his responsibilities include manager due-diligence, idea generation, and market research. During his tenure at the Cleveland Clinic, he has underwritten managers across asset classes including distressed credit, special situations, structured credit, real assets, liquid alternatives and other complex niches. Prior to joining the Cleveland Clinic, he was Senior Analyst at the Rainin Group, a New York City-based single family office where he spent six years sourcing, underwriting, and executing investments in alternative asset managers, private direct investments, and individual public equities. Earlier in his career, he performed equity research for KVO Capital Management in Hanover, New Hampshire. Brent began his career as a Research Associate in the drug discovery group of Rigel Pharmaceuticals. He is a CFA Charterholder, received an MBA with Distinction from the Tuck School of Business at Dartmouth and a BS in Chemistry from UC-Berkeley